Priority Date: 07.06.12 (US 201261656753P)

NANOTHERAPEUTICS FOR DRUG TARGETING

  • Application ID: EP13801368
  • Status: GRANT OF PATENT INTENDED

Applicant

Attorney

operating since 1988
1020.74
Headquarter in London and 1 office
active in Legal Services, IP Consulting, Matchmaking and Trading, IP Portfolio Processing, IPR-related Financial Service, and IP-related Communication Service

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Keltie LLP is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 07.06.2012 - Priority Date (US 201261656753P)
  • 12.12.2013 - Publication A1 (WO2013185032)
  • 15.04.2015 - Publication A1 (EP2858630)